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Abstract 
Dysregulation in signal transduction pathways can lead to a variety of complex disorders, including 
cancer. Computational approaches such as network analysis are important tools to understand system 
dynamics as well as to identify critical components that could be further explored as therapeutic targets. 
Here, we performed perturbation analysis of a large-scale signal transduction model in extracellular 
environments that stimulate cell death, growth, motility, and quiescence. Each of the model's 
components was perturbed under both loss-of-function and gain-of-function mutations. Using 1,300 
simulations under both types of perturbations across various extracellular conditions, we identified the 
most and least influential components based on the magnitude of their influence on the rest of the 
system.  Based on the premise that the most influential components might serve as better drug targets, 
we characterized them for biological functions, housekeeping genes, essential genes, and druggable 
proteins. The most influential components under all environmental conditions were enriched with 
several biological processes. The inositol pathway was found as most influential in the case of 
inactivating perturbations, whereas the kinase pathway and small lung cancer pathway were identified 
as the most influential under activating perturbations. Most influential components under activating 
perturbations were enriched with essential genes when compared to the least influential components. 
Also, the most influential components were enriched with druggable proteins. Moreover, known cancer 
drug targets were also classified in influential components based on the affected components in the 
network. Additionally, the systemic perturbation analysis of the model revealed a network motif of 
most influential components which affect each other. Furthermore, our analysis predicted novel 
combinations of cancer drug targets with various effects on other most influential components. We 
found that the combinatorial perturbation consisting of PI3K inactivation and overactivation of IP3R1 
can lead to increased activity levels of apoptosis-related components and tumor suppressor genes, 
suggesting that this combinatorial perturbation may lead to a better target for decreasing cell 
proliferation and inducing apoptosis. Lastly, our results suggest that systematic perturbation analyses of 
large-scale computational models may serve as an approach to prioritize and assess signal transduction 
components in order to identify novel drug targets in complex disorders. 
1. Introduction 
Recent advances in systems biology and computational biology have introduced methods for the 
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visualization, comprehension, and interpretation of big data in biomedical research.  These fields 
provide an array of methodologies including computer simulations that can be used to generate new 
hypotheses and identify which hypotheses might be more productive to undertake experimentally, and 
eliminate hypotheses with little chance of success (Kitano, 2002a;b;Ghosh et al., 2011).  These 
methods can be effective in navigating complex network problems associated with diseases. Many 
diseases and pathologies can be characterized by the dysregulation or dysfunction of multiple 
molecular components that are connected within these highly intertwined biological and biochemical 
networks (Loscalzo and Barabasi, 2011). Biological networks, including biochemical signal 
transduction networks, consist of a large number of highly interconnected pathways that give rise to 
complex, non-linear dynamics governing various cellular functions (Helikar et al., 2008;Helikar and 
Rogers, 2009). Disruptions of these networks, such as mutations or disease states can have drastic 
effects upon the whole system. These effects are difficult to predict from static network diagrams.  
However, understanding the hierarchy of these changes remains a paramount problem. Often the 
specific causal interactions of the disease state are hidden within the massive cell-wide alterations, 
making attempts to reverse a disease state more challenging. In addition, the specific causal interactions 
are difficult to predict making the development of a potential therapeutic target results in unforeseen 
side effects (Singh and Singh, 2012). The unwanted effects of these drugs are often drastic as seen with 
many cancer medications (Kayl and Meyers, 2006;Lotfi-Jam et al., 2008;Singh and Singh, 2012). 
Therefore, it is necessary to gain a systems level understanding of the components associated with the 
disease states.  
In recent years, targeted therapy has been used for multiple diseases, e.g. cancer (Vanneman and 
Dranoff, 2012), and often involve the activation or inactivation of a specific component in a biological 
network by a small molecule or drug, for instance. Perturbation analyses allow one to interrogate the 
structure and dynamic footprint of the underlying biological system. Perturbation biology has been 
proposed as an approach to reduce the collateral damage caused by nonspecific drugs. Computational 
network perturbations and new methods to evaluate the robustness of a given network can help identify 
more effective network components to target in order to obtain desired outcomes with minimal 
disruption to the rest of the network (Molinelli et al., 2013). 
In order to fully leverage the potential of computational network perturbation analyses large dynamical 
models are necessary. A wide spectrum of modeling approaches exists ranging from detailed (but less 
scalable) differential equation-based systems to large (but not dynamic) static networks. In the middle 
are approaches such as logical modeling that are relatively scalable while capable of capturing the 
dynamic nature of biological systems (Le Novère, 2015). Logical networks, namely Boolean networks, 
have been used to describe and simulate a wide spectrum of biological systems ranging in size as well 
as contextual application (Naldi et al., 2010;Helikar et al., 2012;Madrahimov et al., 2013;Rocha et al., 
2013;Conroy et al., 2014).   
Herein, we present results from a system-wide perturbation analysis of a large-scale Boolean model of 
a signal transduction network widely present in many types of cells. Specifically, the model (previously 
described in (Helikar et al., 2008)) represents signaling events within the integrated epidermal growth 
factor, G-protein coupled receptor, and integrin signaling network. The model consists of 139 
components (mostly proteins) and 557 biochemical interactions. The simulation-based, system-wide 
perturbation analyses enabled us to identify the most and least influential components (ones with the 
most and least impact on the rest of the network). To explore the role and effects of these perturbations 
in the context of the complex extracellular environment, the simulations and analyses were conducted 
under four biologically relevant environmental conditions known to stimulate cell growth, cell death, 
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motility, and quiescence (in addition to a set of randomly generated environmental stimuli). In order to 
investigate potential therapeutic targets, we performed functional annotation and analysis of the most 
influential signal transduction components under both inactivating (e.g. knock-out) and activating (e.g. 
over-expression) perturbations. The most influential components were found to be enriched with many 
biological processes and druggable targets. Also, the most influential components under activating 
perturbations were enriched with more essential genes than the least influential components. We 
identified a network of the most influential components consisting of drug targets considered in 
multiple cancer types. The highest ranked among the most influential components were already 
explored as drug targets against cancer. We used all the most influential components and their upstream 
regulators to identify novel interactions. We used this approach to identify novel drug targets in the 
signal transduction network. As a result of the systemic analysis, we identified one novel combinatorial 
target, PI3K-IP3R1, with consistent occurrence in all simulated environmental conditions. We 
simulated the effect of combinatorial perturbation and the results were correlated with the literature, 
further supporting our predictions.  
2. Materials and Methods 
2.1. Computational Model 
The computational model analyzed in this work is a Boolean model of signal transduction in a generic 
cell type previously described in (Helikar et al., 2008). The signal transduction model was constructed 
manually from around 500 published papers. The model consists of several main signaling pathways, 
including the receptor tyrosine kinase (epidermal growth factor receptor), G-protein coupled receptors 
(G-alpha i, G-alpha q, G-alpha s, and G-alpha 12/13) and the integrin signaling pathways. Each 
component in the model corresponds to a signaling molecule (mainly protein). The model also contains 
nine external components that represent the extracellular environment (mostly composed of receptor 
ligands). It is fully annotated and freely available for simulations and/or download via the Cell 
Collective software (Helikar et al., 2012;Helikar et al., 2013) at www.thecellcollective.org.  
Each model component can assume an active (1) or inactive (0) state at any time t. The activity state of 
the model’s internal components is determined by the regulatory mechanisms of other directly 
interacting components. These regulatory mechanisms are described with Boolean functions (in the 
form of truth tables or Boolean expressions). To represent the milieu of stimuli in the extracellular 
environment, the model contains external components that represent various ligands. The activity level 
of these components is specified as a probability to simulate different levels of concentrations. This 
methodology was previously detailed and exemplified in (Helikar et al., 2008;Helikar and Rogers, 
2009;Helikar et al., 2012;Todd and Helikar, 2012).  
2.2. Model Simulations 
The Cell Collective platform was used to perform all computational simulations of the model. 
Although the model is built by using discrete mathematics the output activity levels (AL) can be 
continuous (ranging from 0 to 100) as previously described in (Helikar et al., 2008;Helikar and Rogers, 
2009). Each simulation is synchronous and consists of 800 steps, where the activity level of the 
measured output component is calculated as the fraction of ones (active states) over the last 300 
iterations that describe the network’s steady behavior (Helikar et al., 2008;Helikar and Rogers, 2009).  
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The model was simulated and analyzed under four biologically-relevant environmental conditions: cell 
growth, cell death, quiescence, motility (and randomly generated conditions). Each environmental 
condition was defined by different combinations of the activity levels of external components (ligands). 
The activity level ranges of the environmental conditions were determined by an optimization method 
whereby 2,000 simulations were run with all external stimuli ranging from 0-100 (except for IL1_TNF 
and Stress that were limited to low activity levels). Subsequently, specific environmental conditions for 
cell growth, cell death, motility, and quiescence were determined by selecting for environmental 
conditions that met the activity levels of biologically relevant model components: Akt, Erk, Cdc42, Rac 
(Helikar et al., 2008). From the initial 2,000 random simulations, environmental conditions that yielded 
the appropriate biological response were averaged and the inclusion of all environmental conditions 
within one standard deviation created an activity range for each of the environmental components 
(Table 1). 
A wild type (WT) experiment was conducted under each environmental condition without any 
perturbations. Subsequently, systematic perturbation experiments were conducted under each 
condition, whereby each component of the model was constitutively activated (gain-of-function/over-
expression) or inactivated (loss-of-function/knock-out). Each experiment consisted of randomly 
selecting 100 combinations of activity levels of the external stimuli from each condition activity range. 
(The only exception was the random environmental condition, which was simulated 2,000 times.) Each 
of the 100 combinations were simulated 30 times (i.e., 30 replicates) to ensure consistency of the 
dynamics in response to a specific combination of stimuli. These replicates were subjected to a Fligner 
Killeen test of homogeneity of variables which confirmed that the measured activity levels of the 
network components were homologous for identical combinations of activity levels of the 
environmental stimuli. 
2.3. Model Analysis 
The Kolmogorov-Smirnov (KS) test (Wang et al., 2003) was used to compare the WT dynamics (under 
each environmental condition) with the dynamics of each perturbation experiment. If the KS test 
resulted in a p-value less than 0.05, then it has a difference value (DV) equal to the test statistic; 
otherwise, the DV for a component is zero. In order to avoid skewed results from the perturbation 
itself, its difference value from the WT is set to zero.  
2.4. Most and Least Influential Components 
The most influential components are defined as components that induce the largest changes in the 
network under a given perturbations. The ranking of the perturbations is derived by calculating an 
influence score (IS), which is found by the summing of each DV for all the components per 
perturbation experiment. The top ten percent are considered most influential, and the bottom 
components with IS value 0 were considered the least influential. 
    ∑ 
   
   
     
         
2.5. Most Affected Components to a Specific Perturbation 
For each perturbation induced, the components that are most sensitive to that perturbation are ranked in 
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decreasing order to be able to characterize downstream effects of the perturbation on the network.  
2.6. Annotation and Biological Relevance of Signal Transduction Components 
All model components were first annotated using the appropriate NCBI gene IDs (Pruitt et al., 2007) 
for associated genes and UniProt IDs (Consortium, 2011) for protein products of the genes. All 
components were then further characterized using online resources such as DrugBank (Wishart et al., 
2006). 
The biological process enrichment analysis of the most influential components was done using DAVID 
(Huang et al., 2008), with high stringency. Gene Ontology (Ashburner et al., 2000), SP_PIR keywords, 
and KEGG pathways (Kanehisa, 2002) were obtained using FDR > 5%.  
Essentiality data were obtained from the Online GEne Essentiality (OGEE) database and mapped on 
the most and least influential components (Chen et al., 2012). DrugBank data were used to obtain 
druggability information for each component in the network.  Data on cancer associated genes were 
obtained from The Cancer Genome Atlas (TCGA) (Weinstein et al., 2013) and mapped on the most 
influential components to identify cancer associated most influential components. The enrichment of 
essential genes and druggable proteins was computed based on the number of genes mapped on most or 
least influential components out of the total number of most and least influential components.  
3. Results 
3.1. System-wide Perturbation Analysis Reveals Core Components of the Signal Transduction 
Network 
A critical objective of biomedical research is the identification and prioritization of novel therapeutic 
targets. In this context, we performed systematic perturbation analysis in a generic signal transduction 
model. The workflow used in this work is illustrated in Figure 1. 
The activating/inactivating perturbation experiments for each component in the model were carried out 
across four environmental conditions (as described in Methods). Additional randomly generated 
extracellular conditions were used to check the robustness of the model and results. Perturbation 
analysis enabled us to identify and rank components of the signaling network that are most and least 
influential (Supplementary Table 1). The heatmaps for all the environmental conditions 
(Supplementary Figures S1-S10) indicate that a few components had high influence on rest of the 
system.  Therefore, we considered the top 10% of the components from each condition as the most 
influential. In contrast, the components that had no influence on the system were considered as the least 
influential (KS=0). 
Also, the most influential components correspond to network components that, when perturbed, affect 
the largest part of the network in terms of the number of affected components and the magnitude of the 
effect.  The most influential components were found for both inactivating (Figure 2 A) and activating 
(Figure 2 B) perturbations under the different environmental conditions. It is interesting to note that 
many of the most influential components overlap across all environmental conditions. However, the 
most influential components do not overlap between two types of perturbations (inactivating or 
activating).  
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3.1.1. Housekeeping Genes are Enriched in the Most Influential Components Common in 
Different Environments 
Next, we investigated if the overlapped most influential components among different environmental 
conditions, have constitutive expression. Under inactivating perturbations, out of the seven components 
common among the different environmental conditions, PI4K, PI5K, ARF and PI3K were associated 
with housekeeping genes (Eisenberg and Levanon, 2013). Under activating perturbations, Trafs, Erk, 
Mek and SHP2 (out of nine common components), were associated with housekeeping genes. 
Housekeeping genes associated with the common components are displayed in Table 2. This 
observation suggests that the most influential components that are common among different 
environmental conditions are likely to function as housekeeping genes.    
3.1.2. Unique components associated with each environmental condition are found to be 
condition specific 
Under both types of perturbations, certain environmental conditions had several uniquely associated 
components (Figure 2, Table 3). Under inactivating perturbations, components uniquely associated 
with the cell death condition are Calmodulin (CaM), RGS, and Palpha_iR. Out of these, CaM and RGS 
have been previously associated with cell death and apoptosis (Fisher, 2009;Berchtold and Villalobo, 
2014).  In fact, CaM plays a central role in the regulation of several cellular functions, including 
programmed cell death (Berchtold and Villalobo, 2014). It is also known that RGS protein can regulate 
cell death, cell cycle and cell division (Fisher, 2009). Under activating perturbations, the most 
influential components associated with the cell death-inducing condition include Gbg_i and Alpha_iR. 
On the other hand, PP2A was found to be most influential under the growth condition, Ras and Sos 
under motility condition, and PAK under quiescence condition.  These results are also further 
supported by published studies that reported Gbg_i (GNB) to be involved in mTOR-mediated anti-
apoptotic pathways;  Gbg_i was also functionally annotated with apoptosis and cell death (Wazir et al., 
2013).  PP2A was reported as a highly regulated Ser/Thr phosphatase involved in cell growth and 
signaling (Janssens and Goris, 2001). In pancreatic cancer cell lines, the knock down of KRAS has 
been found to lead to the decrease in cell motility and proliferation (Rachagani et al., 2011;Birkeland et 
al., 2012). Furthermore, the Grb2-Sos1 complex has been found to most likely promote cell motility, 
and tumerogenesis (Qu et al., 2014).  These observations suggest that the proteins which were uniquely 
associated with simulated environmental conditions are most likely to have the association with that 
condition. Finally, the literature evidence obtained for housekeeping, or condition associated genes, 
further supports our simulation results.  
3.2. Key Biological Processes are Enriched in the Most Influential Components 
Next, we assessed the enrichment of biological processes or pathways in the most influential 
components. The most influential components across all four conditions under both types of 
perturbation showed significant enrichment with key biological processes. The counts and fold 
differences of enriched biological terms in all the conditions are shown in Figure 3 and 4. In the case of 
inactivating perturbations, inositol phosphate metabolism was enriched under all environmental 
conditions (Figure 3). In the case of activating perturbations, the significantly enriched biological 
processes include phosphate metabolic processes, kinase activity, apoptosis and interestingly, the non-
small lung cancer pathway (Figure 4).  These results illustrate that the group of proteins with similar 
biological functions appear as the influential components under each type of perturbation. 
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3.3. The most Influential Components under Activating Perturbations are Enriched with 
Essential Genes  
Mutations in an essential gene can be lethal.  Based on the hypothesis that the influential components 
might serve as essential for the survival of the cell, we performed essentiality analysis. Under 
activating perturbations, more essential genes were found within the most influential components than 
the least influential components (Figure 5 A). Under the cell death environmental condition, a total of 
69% of the most influential components were essential; this is in contrast to the least influential 
components that contained 31% essential genes. Under other environmental conditions- growth, 
motility and quiescence, the difference of essential genes between the most influential and the least 
influential components are 23%, 15%, and 32% respectively.   
On the other hand, under inactivating perturbations we found either an equal or larger number of 
essential genes in the least influential components (Figure 5 B). The most significant differences were 
observed under the cell death condition: the least influential components have 66% of essential genes 
in contrast to the 46% essential genes in the most influential. Also, under the growth condition 68% 
and 53% of essential genes were contained within the least and the most influential components, 
respectively. Under the motility and quiescence conditions, there were 3% and 9% more essential genes 
within the least influential components than the most influential components, respectively.  We found 
that under inactivating perturbations, the number of essential genes among the least influential 
components were slightly larger than the activating perturbation (Figure 5 C and Figure 5 D). On the 
other hand, under activating perturbations, the more essential genes mapped within the most influential 
components than the least influential components. 
Thus, the most influential components are essential under activating perturbations, suggesting an 
environmental condition-specific essentiality. 
3.4. The Most Influential Components are enriched with Druggable Proteins 
To further investigate the importance of the most influential components, we evaluated the distribution 
of known druggable targets.  We obtained druggability data from the DrugBank database (Wishart et 
al., 2006) and mapped them on the most and least influential components. A total of 51 components in 
the whole network were enriched with druggable proteins.  We found that under both types of 
perturbations and across all environmental conditions more druggable proteins were found among the 
most influential than the least influential components (Figure 6).  The enrichment for druggable 
proteins within the most influential components implicates these as critical network components. 
3.5. The Most Influential Components as Drug Targets 
3.5.1. Ranked most influential components based on downstream components  
We identified the most affected components of the most influential components under both types of 
perturbations. We combined all environmental conditions to construct networks of the most influential 
components with their downstream targets. We subsequently mapped druggable proteins and cancer 
associated genes on these networks. Under inactivating perturbations, we obtained a network consisting 
of the most influential components: PI3K, EGFR, PP2A, GRK and CaM (Figure 7 A). Under activating 
perturbations, we obtained a network composed of influential components: EGFR, IL1_TNFR, ERK, 
SHP2, RKIP, Ras, Gbg_i, Fak, Integrins, and PP2A (Figure 7 B).  
Total number of downstream targets for each of the most influential druggable component under both 
inactivating and activating perturbations are listed in Table 4. We observed that EGFR, a validated 
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cancer drug target (Mendelsohn, 2001), affects the largest number of components under activating and 
inactivating perturbations.  
3.5.2. The Most influential components mainly affect other most influential components 
Here, we identified all components that directly affect the activity of each most influential component 
(KS=1). Interestingly, most of these direct upstream components were also ranked as the most 
influential in at least one environmental condition (Figure 8). Under inactivating perturbations, 22 
components were directly upstream of the most influential components. Of these, 19 were the most 
influential under at least one environmental condition. On the other hand, under activating 
perturbations, out of 45 upstream components, 19 were also ranked as most influential. Additionally, 
under inactivating perturbations, nine (CaM, EGFR, Gbg_i, GRK, IP3R1, PP2A, PI3K, Ras, and Src) 
out of total 22 upstream components are druggable. Out of these 22 components, six components 
(CaM, EGFR, Gbg_i, GRK, IP3R1, and PP2A) were upstream to the most influential druggable 
components. Under activating perturbations, 21 (CaM, Cdc42, EGFR, Erk, Fak, Gbg_i, Grb2, GRK, 
IL1_TNFR, Integrins, IP3R1, PDK1, PI3K, PKA, PP2A, Rac, Raf, Ras, RKIP, SHP2, and Src ) out of 
45 upstream to the most influential components are associated with druggable proteins. Out of these 21, 
ten components were also the most influential. Under both types of perturbations, a total of 18 
(alpha_iR, ARF, B_Arrestin, Ca, CaM, EGFR, Gbg_i, GRK, IP3R1, Palpha_iR, PI5K, PIP2_45, 
PIP3_345, PP2A, RGS, PI3K, Ras, Src) upstream components were common.   Nine of these 
components (CaM, EGFR, Gbg_i, GRK, IP3R1, PP2A, PI3K, Ras, and Src) were druggable or these 
were used as the drug targets. The important drug targets such as EGFR, PI3K, Ras, Raf also appeared 
as influential upstream components. Together, these results suggest that under inactivating 
perturbations the activity of the most influential components are likely to be modulated by the other 
most influential components.  
3.5.3. The Most influential Components as Drug Targets, and Drug Resistance  
The top most influential components such as EGFR, PI3K, ERK, and Ras etc. have been previously 
explored as drug targets in multiple cancer types. However, it is also evident from literature that several 
most influential components have been associated with drug resistance. For example, in non-small cell 
lung cancer, mutation within the kinase domain of EGFR, and epithelial–mesenchymal transition are 
responsible for the development of resistance to gefitinib (Holohan et al., 2013). In colorectal, and head 
and neck cancers, KRAS mutation, EGFR-S492R mutation, and increased ErBb signaling are 
responsible for resistance against Cetuximab (Dienstmann et al., 2012;Holohan et al., 2013). 
Furthermore, PI3K showed drug resistance in breast cancer against rapamycin through the expression 
of RSK3 and RSK4 (Rodon et al., 2013). Mutations in ERK1 or ERK2 have shown resistance against 
ERK inhibitors or RAF/MEK inhibitors (Wagle et al., 2014). Tumors with mutation in BRAF V600E 
can adapt to the RAF inhibitors (Lito et al., 2013;Perna et al., 2015). As such, the identification and 
prediction of drug targets alone is not sufficient to identify completely useful drug targets.  
3.6. Regulatory Interactions between the Most Influential components and their Upstream 
Components  
To develop a better strategy that can account for drug resistance of the most important drug targets, we 
sought to investigate novel regulatory interactions. We analyzed the previously described interactions 
between the most influential components and their direct upstream components. We found that some 
interactions consistently occur in more than one environmental condition. For example, the inactivation 
of IP3R1 increases the activity of PI3K under all four environmental conditions. However, the maximal 
effect was observed under the death environmental condition. Additionally, the inactivation of IP3R1 
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leads to inactive RGS under three conditions: cell growth, motility, and quiescence. These finding also 
correlate with published studies that found that RGS positively regulates apoptosis (Fisher, 2009). 
Other examples of consistently occurred interactions include: the activation of Grb2 leads to increased 
activity levels of Ras under all four environmental conditions, and increased Sos activity under death 
and quiescence conditions. The activation of Rac increases the activation of PAK under cell death and 
growth conditions. Overall, we found three types of interactions: inactivation of one component leads 
to the increase of activity of another component (PI3K-IP3R1, IP3R1-PI3K, RGS-IP3R1), inactivation 
of a component leads to decreased activity of another component (IP3R1-RGS), and activation of a 
component leads to increased activity of another component (Grb2-Ras, Grb2-Sos, Rac-PAK).  
The fold differences of all these interactions are displayed in the Table 5.  Under the cell death 
condition, the inactivation of IP3R1 results in PI3K activity increase by 2.38 fold. Similarly, PI3K 
inactivation leads to a 5.42 fold increase in IP3R1 activity. In the case of other interactions, the 
inactivation of IP3R1 leads to inactive RGS under the cell growth, motility and quiescence conditions. 
Under the motility and quiescence conditions, the inactivation of Gbg_i leads to inactive CaM. The 
activation of Grb2 increases the activity of Ras 7.40 fold under the cell death condition, and 2.13 fold 
under the quiescence condition.Grb2 activation also affects Sos 7.8 fold under the cell death condition 
and 2.18 fold under the quiescence condition. An activating perturbation of Rac increases the activity 
of PAK more than 18 fold under the cell death condition, and 5.59 fold under the growth condition. 
These results suggest different types of regulatory effects of activating and inactivating perturbations of 
direct upstream components of most influential components.  
3.7. Co-targeting IP3R1 with PI3K 
As discussed earlier, although PI3K was identified as one of the most influential components, it has 
been also associated with drug resistance. Based on the interactions of upstream regulators of most 
influential components discussed above, we further investigated the interactions involving PI3K and 
IP3R1 with the objective of identifying a secondary drug target that could be potentially used to 
address the issue of PI3K-associated drug resistance. In contrast to PI3K/Akt signaling, IP3R1 
positively regulates apoptosis. We hypothesized that the rate of apoptosis will increase when IP3R1 is 
overactivated (activating perturbation) and PI3K is inactivated (inactivation perturbation). Despite the 
strong dynamical relationship between IP3R1 and PI3K, these two components are only connected 
indirectly through a sub-network.  In this sub-network, Gbg_i is upstream of and directly activates both 
components. IP3R1 regulates PI3K through a Ca->EGFR route, whereas PI3K regulates IP3R1 via a 
PTEN -> PIP2_45 -> IP3 route (Figure 9).  
The inactivating perturbation of PI3K resulted in the inactivation of 29 components across all four 
environmental conditions. Under PI3K inactivation, the average activity of IP3R1 increased from 
71.9% in wild type to 85.18%. This perturbation also led to down-regulation of positive regulators of 
apoptosis phospholipase A2 (PLA2) and arachidonic acid (AA). AA released by PLA2 triggers Ca2+ 
dependent apoptosis through mitochondrial pathways (Penzo et al., 2004). The elevation in Ca2+ is 
thought to be involved in apoptosis (Pinton et al., 2008). It was shown that blocking calcium channels 
can directly lead to tumor promotion (Mason, 1999).  Thus, inactivation of PI3K can block cell 
proliferation; simultaneously it can lower the rate of apoptosis.   
Under growth condition, the activating perturbation of IP3R1 increased the activity of apoptosis-
associated components: Ca, CaM, CaMK, CaMKK and RGS in the range of +1.41 Fold to +2.09 fold 
when compared to wild type. 
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To simulate the cell death effect under growth condition, we carried out a double perturbation of IP3R1 
and PI3K whereby we constitutively activated IP3R1 and inactivated PI3K1. Under this combinatorial 
perturbation, we found 27 proteins including proto-oncogenes such as Akt (which suppresses 
apoptosis) and Raf to be down-regulated. Here, we found eight proteins with more than 19% increased 
activity than in the case of a single inactivating perturbation of PI3K. These proteins include Rap1 (+ 
1.19 Fold), Ca (+ 1.21 Fold), CaM (+1.21 Fold), CaMKK (+ 1.21 Fold), Myosin (+ 1.22 Fold), CaMK 
(+ 1.65 Fold), PLA2 (+ 1.98 Fold), and AA (+1.98 Fold) (Table 6; full list of all affected components is 
given in Supplementary Table 2). It is noteworthy that these components have been found to be 
associated with apoptosis or cell death. Therefore, under combinatorial perturbations, components 
involved in cell proliferation were downregulated through the inactivation of PI3K, and the activity of 
tumor-suppressor genes (PLA2) with arachidonic acid (AA) and other components, including Ca, CaM, 
and CaMK, was increased as a result of the IP3R1 overactivation.  
Together, these results suggest a novel regulatory interaction between PI3K and IP3R1, and that co-
targeting both of these components may serve as therapeutic strategy rather than targeting PI3K alone. 
4. Discussion 
We have presented a systemic perturbation analysis of a signal transduction network model to identify 
and characterize functionally important components. We used these components to explore novel 
therapeutic strategies against cancer. Specifically, we used a logical modeling approach to analyze the 
dynamics of a large-scale signal transduction model. Logical modeling approaches have been used, for 
example, to understand the dynamics of signal transduction and gene regulation networks to identify 
drug synergies in gastric cancers, and to identify potential drug combinations (Flobak et al., 2015). In 
biochemical networks, combined effect of topology and dynamical features have been shown to have 
the most significant impact on the dynamics of the network (Kochi et al., 2014). Computational 
approaches have become indispensable tools to understand biological pathways and disease 
phenotypes. Examples include computational methods such as molecular modeling, text mining, and 
network modeling to identify drug targets in a vast array of diseases from pathogens to complex 
disorders (Flórez et al., 2010;Yao et al., 2010;Folger et al., 2011;Madrahimov et al., 2013;Puniya et al., 
2013).  
In the present work, the identified most influential components were characterized for biological 
functions. The relevance of identified influential components was established with pathway analysis, 
mapping of housekeeping genes, essential proteins, and association with druggable proteins.  
Interestingly, we found enrichment of housekeeping genes in the most influential components that were 
independent of the extracellular environments. A notable agreement is obtained from literature surveys 
for the most influential components, which were unique to specific environmental conditions. Because 
essential components are important from a disease perspective, the identified most influential 
components may serve as potential candidates and essential proteins under specific conditions. Under 
activating perturbations, we found that essential genes were enriched more within the most influential 
components than within the least influential components. The high association of dysregulated signal 
transduction proteins with different subtypes of cancers suggests that these components may be 
important candidates for drug targets. Notably, the most influential components are enriched with 
several already known drug targets. However, many of these drug targets (EGFR, ERK, Ras, PI3K etc.) 
have been associated with drug resistance (West et al., 2002;Kobayashi et al., 2005;Linardou et al., 
2008;Wheeler et al., 2010;Dienstmann et al., 2012). The mechanism of drug resistance includes 
mutation in the targeted protein or expression of other genes (altered expression) to bypass the effect 
caused by perturbation, and deregulation in apoptosis, etc. (Gottesman, 2002;Holohan et al., 2013). 
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Thus, to identify novel regulatory interactions, we explored components that are upstream to the most 
influential components associated with drug resistance. Interestingly, several upstream components 
(more than 90% in the case of inactivating perturbations) to the most influential components were also 
identified as most influential. Thus, the most influential components form a tightly connected sub-
network of proteins interacting with each other. In yeast, it has previously shown that the essential 
proteins are hubs in the network and have more interconnections than non-essential proteins, and form 
a module or sub-network (Song and Singh, 2013).  
The interaction between IP3R1 and PI3K was observed under all environmental conditions. IP3R1 
activation, when combined with PI3K inactivation, increases the activities of PLA2 and AA, which are 
decreased with a single PI3K knockdown. It was already shown that AA released by PLA2 helps to 
initiate apoptosis (Penzo et al., 2004). In a Dictyostelium discoideum chemotaxis experiment, it was 
also shown that cells with PI3K deficiency were more sensitive to PLA2 inhibition (Chen et al., 2007), 
which supports our predicted interaction between PI3K and PLA2. To this end, we hypothesized that 
the PI3K inactivation could be combined with the over-activation of IP3R1 to increase the activity of 
proteins involved in apoptosis. IP3R1 inactivation can lead to the downregulation of RGS, and 
reversibly, the overexpression of IP3R1 can lead to increased activity of RGS. Similar to IP3R1, RGS 
subtype RGS3T has been found to be involved in inducing cell death (Fisher, 2009), and it has also 
been found that RGS can suppress the PI3K activity downstream of the receptor (Liang et al., 2009). 
Therefore, the constitutive activation of IP3R1 might also negatively regulate the activity of PI3K. 
Systemic analysis of the most influential components and their upstream components has led us to 
identify novel combinations of drug targets. In various studies, combinatorial therapies have shown a 
decrease in drug resistance in pathogens. In combinatorial therapy, a protein associated with drug 
resistance can be targeted in combination with different protein of either the same or different pathway 
(Fischbach, 2011). Clinical trials have also suggested that the efficiency of cytotoxic drugs increases 
when given in combinations (Al-Lazikani et al., 2012).  
In conclusion, by combining IP3R1 (activation) and PI3K (inactivation), we were able to stimulate cell 
death under the cell growth condition. Based on this, one can hypothesize that it might be possible that 
the decrease in cell proliferation with increased apoptosis as a result of this combinatorial intervention 
could subsequently increase the rate of clearance of tumor cells, and serve as a novel strategy for 
important targets associated with drug resistance. However, more laboratory validations will be 
required to test this hypothesis.  
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7. Tables 
Table 1: Activity level ranges of environmental stimuli for cell death, growth, motility, 
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quiescence, and random environments 
 
External  Death Growth Motility Quiescence Random 
Extracellular matrix (ECM) 10 - 72 26 - 82 81- 99 7 - 30 0 - 100 
Epidermal Growth Factor (EGF) 3 - 15 72 - 97 29 - 83 43 - 56 0 - 100 
Calcium Pump (ExtPump) 35 - 87 24 - 83 41 - 92 17 - 82 0 - 100 
GPCR q ligand (alpha_qL) 13 - 58 18 - 78 17 - 74 4 - 84 0 - 100 
GPCR i ligand (alpha_iL) 1 - 4 15 - 77 30 - 82 31 - 83 0 - 100 
GPCR s ligand 
(alpha_sL) 
30 - 87 24 - 80 20 - 77 19 - 46 0 - 100 
GPCR 12/13 ligand 
(alpha_1213L) 
14 - 65 18- 78  12 - 77 18 - 67 0 - 100 
IL1_TNF 4 - 13 8 - 15 4 - 13 2 2 
Stress 2 - 5 2 - 5 2 - 5 2 - 3 2 
 
Table 2: Housekeeping genes in the most influential components overlapped among different 
environmental conditions 
 
Perturbation Components Genes Housekeeping genes* 
Inactivating PI4K PI4KA, PI4KB, PIK4CB PI4KA, PI4KB 
PI5K PIP5K1A, PIP5K1B, 
PIP5K1C 
PIP5K1A 
ARF ARFGAP1, ARFGAP2, 
ARFGAP3 
ARFGAP2, ARFGAP3 
PP2A PPP2CA PPP2CA 
PI3K PIK3CA, PIK3CB, PIK3CD, 
PIK3CG 
PIK3C3 , PIK3CB  
Activating EGFR EGFR No 
IL1_TNFR IL1B, TNFRSF1A No 
TRAFS TRAF1, TRAF2, TRAF3, 
TRAF4, TRAF5, TRAF6, 
TRAF7 
TRAF6, TRAF7 
ERK MAPK1 to MAPK15 MAPK1, MAPK6, 
MAPK8, MAPK9 
MEK MAP2K1 to MAP2K7 MAP2K1, MAP2K2, 
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MAP2K5 
PKC PRKCA, PRKCB, PRKCD, 
PRKCE, PRKCG, PRKCH,  
PRKCI, PRKCQ, PRKCZ  
No 
GAB1 GAB1 No 
SHP2 PTPN11 PTPN11 
 
*List of housekeeping genes were obtained from (Eisenberg and Levanon, 2013). 
 
Table 3: Condition specific components and literature support 
 
Perturbations Environmental 
Condition 
Associated 
components 
Literature  
Inactivating Death CaM, RGS, 
Palpha_iR 
CaM and CaM-dependent signaling 
systems control vertebrate cell 
proliferation, programmed cell death 
and autophagy (Berchtold and 
Villalobo, 2014). RGS is involved in 
cell death (Fisher, 2009) 
Activating Death Gbg_i (GNB), 
Alpha_iR 
Gbg_i has been hypothesized to be 
involved in mTOR mediated anti-
apoptotic pathways. Futhermore, it has 
been  
functionally annotated with apoptosis, 
cell death (Wazir et al., 2013) 
Growth PP2A Highly regulated family of Ser/Thr 
phosphatase implicated in  cell growth 
and signaling (Janssens and Goris, 
2001) 
Motility KRAS, Sos Knock-down of KRAS in pancreatic 
cancer cell lines leads to decreased 
motility and proliferation. The 
Grb2-Sos1 complex may promote  cell 
motility, and tumerogenesis (Qu et al., 
2014) 
 
Table 4: Number of downstream targets of the most influential druggable components  
 
 Number of affected 
components 
Number of 
affected druggable 
components 
Number of 
cancer associated 
components 
Perturbation 
EGFR 70 25 8 Inactivating 
17 
 
EGFR 24 13 3 Activating 
IL1_TNFR 54 14 5 Activating 
Erk 54 21 8 Activating 
SHP2 53 17  Activating 
RKIP 43 12 4 Activating 
PI3K 42 17 7 Inactivating 
PP2A 36 14 6 Inactivating 
PP2A 5 3 2 Activating 
Ras 30 13 5 Activating 
GRK 22 5 2 Inactivating 
Gbg_i 15 5 1 Activating 
Fak 14 6 4 Activating 
Integrins 11 3 3 Activating 
CaM 8 5 2 Inactivating 
 
Table 5: Fold differences of the affected most influential component when the upstream 
component was perturbed. 
 
Perturbed 
component 
Affected 
component 
Fold differences (Perturbed/WT) 
Death  Growth Motility Quiescence 
IP3R1 
(inactivation) 
PI3K 2.38 Fold* 1.03 Fold 1.04 Fold 1.14 Fold 
PI3K 
(inactivation) 
IP3R1 5.42 Fold* 1.18 Fold 1.15 Fold 1.24 Fold 
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IP3R1 
(inactivation) 
RGS NSA  complete 
inactivation 
 complete 
inactivation 
 complete 
inactivation 
RGS 
(inactivation) 
IP3R1 NSA 1.21 Fold 1.18 1.24 Fold 
Gbg_i 
(inactivation) 
CaM NSA NSA complete 
inactivation 
complete 
inactivation 
CaM 
(inactivation) 
Gbg_i NSA NSA 1.30 Fold 1.43 Fold 
Grb2 (activation) Ras 7.40 Fold* 1.32 Fold 1.39 Fold 2.13 Fold 
Ras (activation) Grb2 0.99 Fold 0.97 Fold 0.99 Fold 1.01 Fold 
Grb2 (activation) Sos 7.87 Fold* 1.39 Fold 1.53 Fold 2.18 Fold 
Sos (activation) Grb2 1 Fold 0.97 Fold 0.99 Fold 1.01 Fold 
Rac (activation) PAK 18.41 Fold* 5.69 Fold NSA NSA 
PAK (activation) Rac 1.18 Fold 1.24 Fold NSA NSA 
  NSA = Not significantly affected (KST value < 1) 
 * Two fold or above change  
 
Table 6: Activity of affected components under single (PI3K or IP3R1) and double perturbations 
(PI3K and IP3R1) under the cell growth environmental condition 
 
Affected  
components 
PI3K 
inactivation 
(Single 
perturbation)* 
IP3R1 activation 
(Single 
perturbation)* 
Double 
perturbation* 
Functional 
annotation** 
Rap1 3.25 fold 1.07 fold 3.90 fold Tumor 
suppressor gene 
Ca 1.17 fold 1.41 fold 1.43 fold Calcium ion, 
apoptosis 
19 
 
CaM 1.17 fold 1.41 fold 1.43 fold Cell Death 
CaMKK 1.17 fold 1.41 fold 1.43 fold Calcium ion 
binding, 
apoptosis 
Myosin 0.30 fold 1.004 fold 0.36 fold Regulatory light 
chain of myosin 
CaMK 1.33 fold 2.09 fold 2.19 fold may function in 
dendritic spine 
and synapse 
formation and 
neuronal 
plasticity 
PLA2 0.32 fold 1.24 fold 0.63 fold Tumor 
suppressor gene, 
Apoptosis 
AA 0.32 fold 1.24 fold 0.63 fold Apoptosis 
*Compared to the activity of components in wild type.  
** Functional annotations for proteins were obtained from UniProt database and literature. 
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8. Figure Legends 
 
Figure 1: Overview of the method used to assess influential components in the model. 
 
Figure 2: Comparison of the most influential components across simulated environmental 
conditions. (A) Inactivating perturbations, (B) Activating perturbations. 
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Figure 3: Enriched biological processes in the most influential components under environmental 
conditions, and inactivating perturbations. 
 
Figure 4: Enriched biological processes in the most influential components under environmental 
conditions, and activating perturbations. 
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Figure 5: Distribution of essential genes in the most influential components. X-axis= 
environmental conditions, Y-axis = ratio of essential genes in total selected most or least influential 
components in (A) Most influential vs least influential components under activating perturbations (B) 
Most influential vs least influential components under inactivating perturbations (C) Essential genes in 
most influential under inactivating vs activating perturbations (D) Essential genes in least influential 
components under inactivating vs activating perturbations. 
 
Figure 6: Distribution of druggable proteins within the most influential vs least influential 
components. (A) Inactivating perturbations, (B) Activating perturbations. X-axis = environmental 
conditions, Y-axis = ratio of druggable proteins in total most or least influential components. 
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Figure 7: Visualization of the most affected components (KST value =1) as a result of perturbing 
the most influential druggable components. (A) Inactivating perturbations (B) Activating 
perturbations. Orange colored eclipeses = most influential druggable components; squares = affected 
components; orange colored squares= affected druggable components; components with blue borders = 
experimentally found to be associated with cancer. 
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Figure 8: Visualization of the upstream components affecting the most influential components 
(A) Inactivating perturbations (B) Activating perturbations. Grey colored nodes = the most influential 
components, and white colored nodes = not most influential components. The directions of arrows are 
from the source (upstream component) to the target (most influential components).  
 
Figure 9: The regulatory circuit connecting IP3R1 and PI3K. Edges with arrow = activation. Edges 
with oval end = inhibition. 
 
 
 
